| [1] | Ziyun GUO, Lina DU, Xiaoxuan XIE, Yan YANG. Level of vitamin D in children with cholestatic liver disease and its clinical features[J]. Journal of Clinical Hepatology, 2025, 41(1): 99-103. doi: 10.12449/JCH250115 |
| [2] | Jiping ZHANG. Pathological diagnosis of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1093-1099. doi: 10.12449/JCH240605 |
| [3] | Qingqing ZHANG, Ying QU, Xiaobo CAI, Lungen LU. Research advances in animal models of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2023, 39(7): 1754-1760. doi: 10.3969/j.issn.1001-5256.2023.07.035 |
| [4] | Jing LI, Kuiyang ZHENG, Beibei ZHANG. Mechanism of action of bile acid metabolism in regulating cholestatic liver disease and the research and development of drugs[J]. Journal of Clinical Hepatology, 2021, 37(10): 2482-2487. doi: 10.3969/j.issn.1001-5256.2021.10.048 |
| [5] | Yang Ning, Liu YanSheng, Han Ying. Diagnosis and treatment of primary biliary cholangitis-autoimmune hepatitis overlap syndrome[J]. Journal of Clinical Hepatology, 2020, 36(3): 697-700. doi: 10.3969/j.issn.1001-5256.2020.03.051 |
| [6] | Guo MengMeng, Xie Wen. New therapeutic targets and drugs for cholestatic liver disease[J]. Journal of Clinical Hepatology, 2019, 35(2): 262-265. doi: 10.3969/j.issn.1001-5256.2019.02.005 |
| [7] | Kan YanTing, Yang YongFeng. Role of cholestatic liver disease-related genes in intrahepatic cholestasis of pregnancy[J]. Journal of Clinical Hepatology, 2019, 35(7): 1439-1443. doi: 10.3969/j.issn.1001-5256.2019.07.006 |
| [8] | Wang Jing, Zhao LiLi, Shi RuiFang, Liu YongGang, Li Jia. Early treatment of PBC-AIH overlap syndrome with histological remission: A case report[J]. Journal of Clinical Hepatology, 2019, 35(9): 2059-2061. doi: 10.3969/j.issn.1001-5256.2019.09.037 |
| [9] | Pang XiangJun, Xin GuiJie, Zhang Juan, Yan Qi. Primary biliary cholangitis-autoimmune hepatitis overlap syndrome with Wilson's disease: A case report[J]. Journal of Clinical Hepatology, 2019, 35(2): 379-381. doi: 10.3969/j.issn.1001-5256.2019.02.028 |
| [10] | Meng Miao, Hu Zhen, Gong Lei, Lu ZhongHua, Peng XiaoBin, Tang XueJun, Wang XiaoYun. Autoantibody-negative autoimmune hepatitis overlapping with primary biliary cholangitis and primary sclerosing cholangitis: A case report[J]. Journal of Clinical Hepatology, 2019, 35(8): 1806-1808. doi: 10.3969/j.issn.1001-5256.2019.08.032 |
| [11] | Shu YanYun, Pan XiaoLi, Song YuHu, Ye Jin. Clinical features of autoimmune hepatitis and primary biliary cholangitis: A comparative analysis[J]. Journal of Clinical Hepatology, 2019, 35(2): 354-358. doi: 10.3969/j.issn.1001-5256.2019.02.022 |
| [12] | Li ShuXiang, Duan WeiJia, Zhang Dong, You Hong, Jia JiDong. Research advances in autoimmune hepatitis and primary biliary cholangitis in 2017[J]. Journal of Clinical Hepatology, 2018, 34(7): 1569-1572. doi: 10.3969/j.issn.1001-5256.2018.07.044 |
| [13] | Jiang Chao, Huang HeYu, Lu: GuoYue. Perspectives of liver transplantation for infantile cholestatic liver disease[J]. Journal of Clinical Hepatology, 2017, 33(10): 1928-1930. doi: 10.3969/j.issn.1001-5256.2017.10.015 |
| [14] | Wang TingTing, Lu ChangLi, Fan XiaoLi, Yang Li. Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2179-2185. doi: 10.3969/j.issn.1001-5256.2017.11.026 |
| [15] | Li XiaoFeng, Gong JingYu, Wang JianShe. Association between enterohepatic circulation of bile acid and cholestatic liver disease[J]. Journal of Clinical Hepatology, 2017, 33(10): 1922-1927. doi: 10.3969/j.issn.1001-5256.2017.10.014 |
| [16] | Lyu Sa, You ShaoLi, Tian Hua, Song FangJiao, Liu WanShu, Wang HaiBo, Li Chen, Liu LiMin, Zhu Bing. Clinical features of 181 patients with cholestatic autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(8): 1527-1531. doi: 10.3969/j.issn.1001-5256.2017.08.024 |
| [17] | Sun FengXia, Sui JingLi, Li Pan, Wang Man, Wu Fang, Li XiaoLing. Biochemical parameters in diagnosis of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2016, 32(8): 1488-1490. doi: 10.3969/j.issn.1001-5256.2016.08.011 |
| [18] | Ye Qing, Han Tao, Li Ning. Clinical value of serum soluble intercellular adhesion molecule-1 in patients with primary biliary cirrhosis and autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(5): 417-420. doi: 10.3969/j.issn.1001-5256.2014.05.008 |
| [19] | Li Bing, Shao Qing, Niu XiaoXia, Zhang Jian, Chen GuoFeng. Clinical features and diagnosis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J]. Journal of Clinical Hepatology, 2014, 30(5): 413-416. doi: 10.3969/j.issn.1001-5256.2014.05.007 |
| [20] | Chu JinDong, Zhu JiangYi, Gao ZhengJun, Zhu ShaoHua, Dong XuYang, Han ZheYi, Shi YongQuan, Zhou XinMin, Han Ying. Observation of clinical feature and curative efficacy on autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J]. Journal of Clinical Hepatology, 2012, 28(5): 343-348. |
DownLoad: